{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:15:42Z","timestamp":1783530942742,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,8]]},"DOI":"10.7759\/cureus.112284","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:31:38Z","timestamp":1783528298000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Sepsis in an Adolescent With a De Novo Variant in the EP300 Gene Associated With Rubinstein-Taybi Syndrome Type 2: A Case Report"],"prefix":"10.7759","author":[{"given":"Adriana","family":"Pinheiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia F","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/genes12070968","article-title":"Rubinstein-Taybi syndrome: a model of epigenetic disorder","volume":"12","author":"Van Gils J","year":"2021","unstructured":"Van Gils J, Magdinier F, Fergelot P, Lacombe D. Rubinstein-Taybi syndrome: a model of epigenetic disorder. Genes (Basel). 2021, 12:968. 10.3390\/genes12070968","journal-title":"Genes (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2023-109438","article-title":"Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement","volume":"61","author":"Lacombe D","year":"2024","unstructured":"Lacombe D, Bloch-Zupan A, Bredrup C, et al.. Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement. J Med Genet. 2024, 61:503-19. 10.1136\/jmg-2023-109438","journal-title":"J Med Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1086\/429130","article-title":"Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease","volume":"76","author":"Roelfsema JH","year":"2005","unstructured":"Roelfsema JH, White SJ, Ariy\u00fcrek Y, et al.. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet. 2005, 76:572-80. 10.1086\/429130","journal-title":"Am J Hum Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgz149","article-title":"Mutations in CREBBP and EP300 genes affect DNA repair of oxidative damage in Rubinstein-Taybi syndrome cells","volume":"41","author":"Dutto I","year":"2020","unstructured":"Dutto I, Scalera C, Tillhon M, et al.. Mutations in CREBBP and EP300 genes affect DNA repair of oxidative damage in Rubinstein-Taybi syndrome cells. Carcinogenesis. 2020, 41:257-66. 10.1093\/carcin\/bgz149","journal-title":"Carcinogenesis"},{"key":"ref5","article-title":"Rubinstein-Taybi syndrome","author":"Stevens CA","year":"2023","unstructured":"Stevens CA. Rubinstein-Taybi syndrome. GeneReviews\u00ae [Internet]. Adam MP, Bick SL, Mirzaa GM, et al. (ed): University of Washington, Seattle (WA); 2023."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38603","article-title":"Benign and malignant tumors in Rubinstein-Taybi syndrome","volume":"176","author":"Boot MV","year":"2018","unstructured":"Boot MV, van Belzen MJ, Overbeek LI, et al.. Benign and malignant tumors in Rubinstein-Taybi syndrome. Am J Med Genet A. 2018, 176:597-608. 10.1002\/ajmg.a.38603","journal-title":"Am J Med Genet A"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.61883","article-title":"EP300-related Rubinstein-Taybi syndrome: highlighted rare phenotypic findings and a genotype-phenotype meta-analysis of 74 patients","volume":"182","author":"Cohen JL","year":"2020","unstructured":"Cohen JL, Schrier Vergano SA, Mazzola S, et al.. EP300-related Rubinstein-Taybi syndrome: highlighted rare phenotypic findings and a genotype-phenotype meta-analysis of 74 patients. Am J Med Genet A. 2020, 182:2926-38. 10.1002\/ajmg.a.61883","journal-title":"Am J Med Genet A"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37940","article-title":"Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations","volume":"170","author":"Fergelot P","year":"2016","unstructured":"Fergelot P, Van Belzen M, Van Gils J, et al.. Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. Am J Med Genet A. 2016, 170:3069-82. 10.1002\/ajmg.a.37940","journal-title":"Am J Med Genet A"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-019-01985-y","article-title":"Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders","volume":"138","author":"Negri G","year":"2019","unstructured":"Negri G, Magini P, Milani D, et al.. Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders. Hum Genet. 2019, 138:257-69. 10.1007\/s00439-019-01985-y","journal-title":"Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00808-4","article-title":"Prevalence of immunological defects in a cohort of 97 Rubinstein-Taybi syndrome patients","volume":"40","author":"Saettini F","year":"2020","unstructured":"Saettini F, Herriot R, Prada E, et al.. Prevalence of immunological defects in a cohort of 97 Rubinstein-Taybi syndrome patients. J Clin Immunol. 2020, 40:851-60. 10.1007\/s10875-020-00808-4","journal-title":"J Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12671","article-title":"Antibody deficiency in Rubinstein-Taybi syndrome","volume":"89","author":"Herriot R","year":"2016","unstructured":"Herriot R, Miedzybrodzka Z. Antibody deficiency in Rubinstein-Taybi syndrome. Clin Genet. 2016, 89:355-8. 10.1111\/cge.12671","journal-title":"Clin Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/adc.83.4.360","article-title":"Rubinstein-Taybi syndrome with humoral and cellular defects: a case report","volume":"83","author":"Villella A","year":"2000","unstructured":"Villella A, Bialostocky D, Lori E, Meyerson H, Hostoffer RW. Rubinstein-Taybi syndrome with humoral and cellular defects: a case report. Arch Dis Child. 2000, 83:360-1. 10.1136\/adc.83.4.360","journal-title":"Arch Dis Child"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.44526","article-title":"Clinical variant reclassification in hereditary disease genetic testing","volume":"7","author":"Kobayashi Y","year":"2024","unstructured":"Kobayashi Y, Chen E, Facio FM, et al.. Clinical variant reclassification in hereditary disease genetic testing. JAMA Netw Open. 2024, 7:e2444526. 10.1001\/jamanetworkopen.2024.44526","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cphg.93","article-title":"Overview of specifications to the ACMG\/AMP variant interpretation guidelines","volume":"103","author":"Harrison SM","year":"2019","unstructured":"Harrison SM, Biesecker LG, Rehm HL. Overview of specifications to the ACMG\/AMP variant interpretation guidelines. Curr Protoc Hum Genet. 2019, 103:e93. 10.1002\/cphg.93","journal-title":"Curr Protoc Hum Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17:405-24. 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0631","article-title":"Recommendations for cancer surveillance in individuals with RASopathies and other rare genetic conditions with increased cancer risk","volume":"23","author":"Villani A","year":"2017","unstructured":"Villani A, Greer MC, Kalish JM, et al.. Recommendations for cancer surveillance in individuals with RASopathies and other rare genetic conditions with increased cancer risk. Clin Cancer Res. 2017, 23:e83-90. 10.1158\/1078-0432.CCR-17-0631","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36883","article-title":"Expanding the phenotypic spectrum in EP300-related Rubinstein-Taybi syndrome","volume":"167A","author":"Solomon BD","year":"2015","unstructured":"Solomon BD, Bodian DL, Khromykh A, et al.. Expanding the phenotypic spectrum in EP300-related Rubinstein-Taybi syndrome. Am J Med Genet A. 2015, 167A:1111-6. 10.1002\/ajmg.a.36883","journal-title":"Am J Med Genet A"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/488459-severe-sepsis-in-an-adolescent-with-a-de-novo-variant-in-the-ep300-gene-associated-with-rubinstein-taybi-syndrome-type-2-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:31:38Z","timestamp":1783528298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/488459-severe-sepsis-in-an-adolescent-with-a-de-novo-variant-in-the-ep300-gene-associated-with-rubinstein-taybi-syndrome-type-2-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.112284","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,8]]}}}